1. IL-37 Inhibits Inflammation of Lacrimal Gland in Dry Eye Mice via the IL-37-PTEN-NFκB Signaling Pathway.
- Author
-
Qi X, Yang Y, Xiong D, Lin B, Wu S, Chen M, Jiang Z, and Zhang Q
- Subjects
- Animals, Mice, Blotting, Western, Female, Mice, Inbred C57BL, Injections, Intraperitoneal, PTEN Phosphohydrolase metabolism, Dry Eye Syndromes drug therapy, Dry Eye Syndromes metabolism, Signal Transduction, Lacrimal Apparatus metabolism, Lacrimal Apparatus drug effects, Lacrimal Apparatus pathology, Disease Models, Animal, NF-kappa B metabolism, Tears metabolism, Interleukin-1 metabolism
- Abstract
Purpose: This study aims to investigate the role of Interleukin-37 (IL-37) in mouse models of dry eye., Methods: Two murine models of dry eye were employed in this investigation. The evaluation of the anti-inflammatory impact of IL-37 (200 μl, 10 μg/ml) on dry eye mice involved intraperitoneal injections administered once daily for 7 days. Additionally, intraperitoneal injection of VO-Ohpic trihydrate (VO, 0.25 mg/kg) in dry eye mice was performed to investigate the role of PTEN in the IL-37 anti-inflammatory signaling pathway. Tear production was assessed using phenol red cotton thread, while corneal damage was examined through sodium fluorescein staining using a slit lamp. Histological alterations in the lacrimal gland were observed through H&E staining. PAS staining was used to assess conjunctival goblet cells. The levels of NFκB-P65, p-NFκB-P65, IL-1β, IL-6, TNF-α, CD3, AQP5, α-SMA and PTEN proteins were determined via Western blotting or immunofluorescence., Results: Following IL-37 treatment, both dry eye models exhibited reduced corneal fluorescence staining scores and enhanced tear production. In lacrimal gland, the expression of p-NFκB-P65, IL-1β, IL-6, CD3 and TNF-α was diminished, while PTEN, AQP5, α-SMA expression increased after IL-37 treatment in both dry eye mice. However, the intraperitoneal injection of VO significantly attenuated the anti-inflammatory effect of IL-37 on dry eye mice., Conclusion: IL-37 emerges as an anti-inflammatory mediator within the lacrimal gland of dry eye mice, exerting its effects through the IL-37-PTEN-NFκB signaling pathway.
- Published
- 2024
- Full Text
- View/download PDF